Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Sell
19
YETI Quote, Financials, Valuation and Earnings
Last price:
$34.21
Seasonality move
:
2.9%
Day range:
$32.32 - $34.81
52-week range:
$31.48 - $45.25
Dividend yield:
0%
P/E ratio:
15.62x
P/S ratio:
1.51x
P/B ratio:
3.58x
Volume:
1.6M
Avg. volume:
2M
1-year change:
-8.23%
Market cap:
$2.7B
Revenue:
$1.8B
EPS (TTM):
$2.06
YETI Holdings Number of Institutional Trades
YETI Holdings Volume of Institutional Trades
Amount of Institutions Buying
--
(Last Month)
Amount of Institutional Buying
$8.3B
(Last 6 Months)
Current Institutional Ownership Percentage
--
Amount of Institutions Selling
--
(Last Month)
Amount of Institutional Selling
$11.2B
(Last 6 Months)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
YETI Holdings Institutional Ownership
-
What Percentage Of YETI Is Owned by Institutions?
-- of YETI is owned by institutions.
-
How Many Institutions Own YETI Shares?
YETI Holdings stock is owned by 838 institutional shareholders at this time.
-
Have Institutions Been Buying YETI Stock?
Yes, institutions have bought 132.9M shares of YETI in the last quarter.
-
Have Institutions Been Selling YETI Stock?
Yes, institutions have sold 165.9M shares of YETI over the last quarter.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is the Market Going to Go Lower?
The last month has been extremely difficult for the stock…
2 Dividend Stocks to Buy in a Recession
While many economists and investors initially expected 2025 to be…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
54
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Buy
52
RGC alert for Mar 18
Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.
Buy
63
EXOD alert for Mar 18
Exodus Movement [EXOD] is down 3.96% over the past day.
Sell
45
MNPR alert for Mar 18
Monopar Therapeutics [MNPR] is up 0.93% over the past day.
